FDA granted accelerated approval to Astellas and Seagen PADCEV for people with locally advanced or metastatic urothelial cancer
On Dec. 18, 2019, Seagen and Astellas Pharma announced the U.S. Food and Drug Administration (FDA) had granted…
On Dec. 18, 2019, Seagen and Astellas Pharma announced the U.S. Food and Drug Administration (FDA) had granted…
On Dec. 17, 2019, the University of Alabama at Birmingham Comprehensive Cancer Center (UAB) announced that Gregory Friedman,…
On Dec. 13, 2019, the Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee (ACIP)…
On Dec. 13, 2019, the Masonic Cancer Center joined the National Institute of Environmental Health Sciences Study, Human…
On Dec. 12, 2019, BioAegis Therapeutics announced publication of new research findings with recombinant human plasma gelsolin in…
On Dec. 12, 2019, Vanderbilt University Medical Center (VUMC) researchers James Crowe Jr., MD, and colleagues announced they…
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
On Dec. 11, 2019, Dennis Eggers became the first patient in a new clinical trial to receive a…
On Dec. 10, 2019, Georgia Institute of Technology alumni and co-founders of LymphaTech Nate Frank and Mike Weiler…
On Dec. 4, 2019, PATH announced that its Board of Directors had unanimously chosen global development leader Nikolaj…
On Dec. 3, 2019, the Cold Spring Harbor Laboratory researchers with colleagues at UConn Health and Jackson Laboratory…
On Dec. 2, 2019, the U.S. Food and Drug Administration (FDA) announced it had approved the drug crizanlizumab…
On Dec. 2, 2019, the University of Tennessee Institute of Agriculture announced it had received a grant by…
On Nov. 25, 2019, Dr. Claudia Kleinman, Dr. Nada Jabado, and Dr. Michael Taylor discovered that pediatric brain…
On Nov. 24, 2019, Abu Dhabi Health Services Company, the largest healthcare network in the United Arab Emirates…
On Nov. 22, 2019, the Centers for Disease Control and Prevention”s (CDC) Advisory Committee on Immunization Practices (ACIP)…
On Nov. 20, 2019, University of California San Diego (UCSD) researchers provided new insights into a key pathway…
On Nov. 20, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 10 new recruitment grants,…
On Nov. 20, 2019. Bristol-Myers Squibb announced it had completed its acquisition of Celgene. On Jun. 29, 2015,…
On Nov. 19, 2019, Novo Ventures and the Broad Institute of MIT and Harvard announced the launch of…
On Nov. 13, 2019, researchers at University of California San Diego (UCSD) School of Medicine announced that they…
On Nov. 12, 2019, Calporta Therapeutics, one of eight San Diego biotech companies Avalon Ventures created with GlaxoSmithKline,…
On Nov. 7, 2019, Ceres Nanosciences announced the commercial launch of the Nanotrap Virus Capture Kit. The Nanotrap…
On Nov. 6, 2019, Abbott announced that a team of its scientists identified a new subtype of the…
On Nov. 4, 2019, the U.S. Food and Drug Administration (FDA) approved Fluzone High-Dose Quadrivalent (Sanofi Pasteur) for…
On Oct. 30, 2019, researchers at the University of Georgia’s Center for the Ecology of Infectious Diseases received…
On Oct. 30, 2019, the Barbara Ann Karmanos Cancer Institute established the McLaren Proton Therapy Center, one of…
On Oct. 30, 2019, philanthropist Jay Alix extended his generosity with an additional $15 million endowed gift to…
On Oct. 27, 2019, the Leona M. and Harry B. Helmsley Charitable Trust announced it had awarded $13…
On Oct. 22, 2019, scientists at Sanford Burnham Prebys announced they had developed a machine-learning algorithm that gleans…